Through the analysis of genomic datasets, the authors revealed that wild-type IDH2 mRNA expression was significantly elevated in breast cancer, particularly in TNBC, correlating with advanced clinical stages (Figure 1). This evidence concerns the gene IDH2 and breast carcinoma.